March 5, 2026: Rybelsus Manufacturer, Novo Nordisk, Cited for Not Reporting Adverse Drug Events to FDA The FDA has sent a warning letter to Novo Nordisk because it says the companys written policies for tracking, reporting, and evaluating postmarketing adverse drug experiences to the FDA were insufficient
1028-39, (2015) (PubMed)
Check for such things as: changes in the color or temperature of your toes or feet changes in the bony shape of the toes or feet (you can even have a broken foot bone and not be able to feel it) new numbness or loss of feeling in the toes or feet a buildup of corns, calluses, and blisters dry, or cracked skin or skin that does not look normal open sores
The relative cost of each comparator was calculated by dividing the annual cost with the comparator by the annual cost of once-weekly semaglutide
It's important to rotate your injection site each week
Since it impacts insulin, it can act as a supplemental medication for diabetics to keep their condition and overall health in check